Statin discontinuation, compared with continued use, did not raise all-cause mortality over 3 years among adults aged at least 75 years who were taking statins for primary prevention of atherosclerotic cardiovascular disease.For older adults on statin therapy for primary prevention of ASCVD, discontinuation of statin therapy conferred similar adverse event rates and quality of life scores vs.